Advances in CHO Cell Line Development for Biotherapeutics
The landscape of biotherapeutic production is rapidly evolving, driven by an increasing demand for more complex recombinant proteins and a shift toward personalized medicine.
Article
Published: November 17, 2023
Written by
Credit: iStock
Biotherapeutics have revolutionized medicine, offering targeted treatments for a wide range of diseases. As the field moves toward increasingly complex molecules like bispecific antibodies, the demand for efficient, high-yield cell line development has never been greater.
Recent breakthroughs in automation, gene editing and epigenetic regulation are accelerating the optimization of mammalian cell lines.
Continue reading this article to explore how cutting-edge research is enhancing cell line development, reducing production timelines and paving the way for more advanced and accessible biologic therapies.
Sponsored by
Meet the Author
Freelance Science Communications Specialist
View this Article for FREE Now!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
Experiencing issues viewing the form? Click here to access an alternate version
